CSI Market
Sign In | Register

(HGH) Quarterly Income Statement

Quarterly · GAAP · USD millions
Access HGH Annual Income Statement →
By examining income statement figures across successive periods, users can identify shifts in 's profitability and expense structure.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Quarterly Report, GAAP in USD millions
ITEM 		(Jun 30 2026)
Q2 2026 		(Dec 31 2022) (Sep 30 2019) (Jun 30 2019) (Dec 31 2014)
Revenues
Sales of Products111.00
Total Revenue7,263.00
Costs & Expenses
Cost of Goods and Services Sold669.00
Gross Profit6,594.00
Selling, Administration, Marketing1,215.00
Depreciation & Amortization17.00
Total operating costs including COS0.00
Operating income / -loss0.00
Interest Expense50.00
Net Interest Expense / -Income0.00
Extinguishment of Debt0.00
Loss / -Gain on Investment800.00
Total costs & expenses6,032.00
Income & Taxes
Income / -loss before income taxes1,231.00
Income taxes expenses / -benefit251.00
Income after income taxes980.00
Income / -loss from continuing operations980.00
Discontinued operations318.00
Preferred dividends5.00
Net income / -loss1,298.00
Income / -loss to shareholder1,293.00
EBIT1,231.00
EBITD1,321.00
EBITDA2,172.00
Earnings Per Share
Basic EPS (excl. extra items)3.57
Extraordinary items1.16
Basic Net EPS4.73
Basic shares outstanding (Mill. of Units)273.30
Diluted Net EPS4.68
Diluted average shares (Mill. of Units)276.30
Dividend per share0.60
4 historic quarters locked

Sign in to unlock the full income statement history.

Sign In Create Free Account